Author

Therica M. Miller

Observed names: Miller, Therica M., Therica M Miller, Therica Miller

Institution: Tisch Cancer Institute

Observed institutions: Cedars-Sinai Medical Center, Hartford Hospital, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai

ORCID: 0000-0002-4086-3076

Observed ORCID: 0000-0002-4086-3076

OpenAlex ID: A5044373838

PRISM: Patient Records Interpretation for Semantic clinical trial Matching system using large language models

2024 · Shashi Gupta, Aditya Basu, et al. · npj Digital Medicine · 54

A call to action to advance patient‐focused and decentralized clinical trials

2024 · R. Donald Harvey, Therica M. Miller, et al. · Cancer · 29

Improving Access to Patient-Focused, Decentralized Clinical Trials Requires Streamlined Regulatory Requirements: An ASCO Research Statement

2024 · Ramya Thota, Patricia A. Hurley, et al. · Journal of Clinical Oncology · 21

Sponsor Perspectives on the Impact of the COVID-19 Pandemic on Interventional Cancer Clinical Trial Protocols and Data Quality

2023 · Joseph M. Unger, Hillary Stires, et al. · JCO Oncology Practice · 10

Impact of the COVID-19 Pandemic Mitigation Strategies on Cancer Treatment Trials: A Meta-Analysis of Industry and National Cancer Institute Studies

2025 · Joseph M. Unger, Hillary S. Andrews, et al. · JCO oncology advances. · 7

21 Code of Federal Regulations Part 11–Compliant Digital Signature Solution for Cancer Clinical Trials: A Single-Institution Feasibility Study

2020 · Therica M. Miller, Jenny Lester, et al. · JCO Clinical Cancer Informatics · 2

Accelerating the clinical trial start-up process for early-phase cancer studies: A test of process change to support rapid activation in an academic medical center.

2013 · Sheilah K Hurley, Therica M Miller, et al. · Journal of Clinical Oncology · 2

PRISM: Patient Records Interpretation for Semantic Clinical Trial Matching using Large Language Models

2024 · Gupta, Shashi Kant, Basu, Aditya, et al. · arXiv (Cornell University) · 1

Impact of the COVID-19 pandemic mitigation strategies on cancer treatment trials: A meta-analysis of industry and NCI studies.

2024 · Joseph M. Unger, Hillary Andrews, et al. · Journal of Clinical Oncology

Impact of COVID-19 pandemic mitigation strategies on industry and NCI cancer treatment trials.

2023 · Joseph M. Unger, Caroline Schenkel, et al. · Journal of Clinical Oncology

Works count: 10

Citation count: 126

H-index: 5

I10-index: 4